Financing channel feed – Endpoints News

Financing channel feed

Female investors track progress, call for more women on boards and in leadership roles

Last year

Pfizer-backed UK biotech raises £25M to advance mitophagy pipeline

Last year

German ADC biotech Tubulis raises $138M to enter the clinic and expand in US

Last year

Swedish biotech raises €30M Series A to develop off-the-shelf gene therapy for solid tumors

Last year

Exclusive: ‘ChatGPT for DNA’: Relation nabs $35M, with Nvidia backing, for osteoporosis work

Last year

FOMO, detox and depth: Why this biotech rally may (finally) be real

Last year

Early-stage oncology startup Boundless Bio files for IPO

Last year

As the biotech markets warm up, signs point to crossover rounds returning

Last year

Alumis closes a $259M Series C to back its TYK2, flirts with talk about an IPO

Last year

Sionna raises $182M for cystic fibrosis drugs different from Vertex's approach

Last year

Spanish VC preps launch for €100M fund with an emphasis on advanced therapies

Last year

Cormorant nears the close of fifth private healthcare fund as biotech industry sees greener pastures

Last year

Ally Bridge beefs up 'new generation' as investment firm passes 10-year mark

Last year

Exclusive: Nocion raises $62M for different approach to chronic cough than Merck, GSK

Last year

Exclusive: Backed by MIT’s Andrew Lo, Quantile Health raises $6M to bolster gene therapy access

Last year

FogPharma bags $145M, adds Alexis Borisy to the board

Last year

'Sweet spot' of CNS cell therapy: Kenai emerges with $82M for Parkinson's study

Last year

BlossomHill raises $100M in bid to repeat founders' cancer success at Turning Point

Last year

Novo Holdings invests in macrocycle startup Orbis as once-overlooked molecules get new interest

Last year

Biotech index rises above $100 mark for first time in two years

Last year

GV backs hair loss biotech out of UCLA with PhII set for mid-2024

Last year

UK biotech draws Pfizer backing in £40.5M Series A for peptide-inspired drugs

Last year

Frontier Medicines raises $80M, enters clinic and eyes potential IPO in Q4 or early 2025

Last year

Simone Song's ORI Capital closes $260M second fund after CG Oncology success

Last year

First page Previous page 17 18 192021 22 23 Next page Last page